# FDA Inspection 572931 - GlaxoWellcome Production - March 19, 2009

Source: https://www.globalkeysolutions.net/records/fda_inspections/glaxowellcome-production/f810f8e2-738a-47ae-a4fa-1bed8021c1aa/
Source feed: FDA_Inspections

> FDA Inspection 572931 for GlaxoWellcome Production on March 19, 2009. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 572931
- Company Name: GlaxoWellcome Production
- Inspection Date: 2009-03-19
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1242271 - 2022-04-08](https://www.globalkeysolutions.net/api/records/fda_inspections/glaxowellcome-production/20e1d573-049b-4112-8240-f10261c65444/)
- [FDA Inspection 1005796 - 2017-03-03](https://www.globalkeysolutions.net/api/records/fda_inspections/glaxowellcome-production/b673f0a0-aaff-450b-b76a-74f9a1411f35/)
- [FDA Inspection 886660 - 2014-04-11](https://www.globalkeysolutions.net/api/records/fda_inspections/glaxowellcome-production/e4e092cb-d373-415d-ba98-4c6896833c08/)
- [FDA Inspection 772742 - 2012-02-27](https://www.globalkeysolutions.net/api/records/fda_inspections/glaxowellcome-production/26c5734a-d28c-4562-b34f-1069d1f34bf5/)

Company: https://www.globalkeysolutions.net/companies/glaxowellcome-production/f88b8738-02c0-496c-bdc6-4d9f893e1cb8

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c